- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04532034
Facilitating Engagement in Evidence-Based Treatment for Early Psychosis
March 20, 2024 updated by: Temple University
Facilitating Emerging Adults Engagement in Evidenced-Based Treatment for Early Psychosis Through Peer-Delivered Decision Support
The purpose of this mixed methods study is to evaluate a peer-delivered decision support intervention with emerging adults newly enrolled in an early intervention program, also known as coordinated specialty care (CSC).
It is hypothesized that participants will experience a reduction in decision-making needs after participating in the intervention, and that study and intervention procedures will demonstrate feasibility and acceptability.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The overarching goal of this study is to pilot test a peer-delivered decision support intervention (in the form of decision coaching) that is designed to enhance emerging adults' treatment decision-making and service engagement after enrollment in a coordinated specialty care (CSC) program.
Based on an experimental therapeutics approach, this mixed methods pilot trial will assess feasibility, acceptability, and the intervention's potential impact on key decision-making needs (i.e., decision-making targets).
We will track feasibility data related to study and intervention procedures, and collect acceptability and outcome data from 20 emerging adults who will participate in the intervention after enrollment in the CSC program.
Quantitative analysis related to decision-making targets will provide preliminary evidence regarding whether the intervention impacts these targets, while qualitative analysis will explain how it may do so.
Merged results from these two sets of data will inform intervention refinement by providing a nuanced understanding of the intervention's potential to engage decision-making targets from the perspective of emerging adults.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Elizabeth Thomas, Ph.D.
- Phone Number: 215-204-1699
- Email: tug66715@temple.edu
Study Locations
-
-
Pennsylvania
-
Broomall, Pennsylvania, United States, 19008
- Child and Family Focus (On My Way Program)
-
Danville, Pennsylvania, United States, 17821
- CMSU Behavioral Health & Developmental Services
-
Philadelphia, Pennsylvania, United States, 19150
- Horizon House
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 18-30 years of age
- Experiencing early psychosis,defined as psychosis lasting 18 months or less between the time when threshold symptom criteria were reached (as determined by the admitting CSC program assessor) and the date of CSC program enrollment
- Able to speak/understand English
- Able to provide informed consent as assessed by research staff
- Enrolled in the CSC program for any period of time
Exclusion Criteria:
- having a legal guardian
- Diagnosis of dementia, delirium, or intellectual disability as determined by the admitting CSC program psychiatrist
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Peer-Delivered Decision Support Intervention
|
An intervention provided by a trained peer interventionist to facilitate treatment decision making among emerging adults with early psychosis.
Specific components of this intervention may include facilitating access to information, clarifying values, helping a person obtain the needed support to make a decision, and screening for implementation barriers.
Due to having lived experience of a mental health condition, the peer interventionist will also be able to provide unique types of information and support within the coaching process.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Decisional Conflict Scale
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Decisional Conflict Scale value at intervention completion minus the value at baseline.
Total scores on the Decisional Conflict Scale are calculated as: (sum of all items scores / the total number of items) x 25.
For this study, 9 items were included.
Scores on the Decisional Conflict Scale range from 0-100, with higher scores indicating a worse outcome.
|
Baseline, through intervention completion (up to 3 months)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Multidimensional Scale of Perceived Social Support
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Multidimensional Scale of Perceived Social Support value at intervention completion minus the value at baseline.
Full scale scores range from 12-84, with higher scores indicating a better outcome.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Control Preference Scale
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Control Preference Scale value at intervention completion minus the value at baseline.
Scores on the Control Preference Scale range from 1-11; higher scores indicate less of a preference for control in decision-making.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Perceived Involvement in Care Scale
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Perceived Involvement in Care Scale value at intervention completion minus the value at baseline.
Scores on the Perceived Involvement in Care Scale range from 0-13, with higher scores indicating a better outcome.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Birchwood Insight Scale
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Birchwood Insight Scale value at intervention completion minus the value at baseline.
Scores on the Birchwood Insight Scale range from 0-12, with higher scores indicating a better outcome.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Internalized Stigma of Mental Illness Scale
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Internalized Stigma of Mental Illness Scale value at intervention completion minus the value at baseline.
Scores on the Internalized Stigma of Mental Illness Scale range from 1-4, with higher scores indicating a worst outcome.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Empowerment Scale
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Empowerment Scale value at intervention completion minus the value at baseline.
Scores on the Empowerment Scale range from 28-112, with higher scores indicating a better outcome.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Decision-Self-Efficacy Scale
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Decision Self-Efficacy Scale value at intervention completion minus the value at baseline.
Scores on the Decision Self-Efficacy Scale range from 0-100, with higher scores indicating a better outcome.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Recovery Assessment Scale
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Recovery Assessment Scale value at intervention completion minus the value at baseline.
Scores on the Recovery Assessment Scale range from 24-120, with higher scores indicating a better outcome.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Number of Outpatient Mental Health Visits (Service Use and Resources Form)
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the number of outpatient mental health visits at intervention completion minus the number of outpatient mental health visits at baseline according to the Service Use and Resources Form.
The minimum score is 0; there is no maximum score.
Higher scores indicate greater service utilization.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Brief Adherence Rating Scale
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Brief Adherence Rating Scale value at intervention completion minus the value at baseline.
Scores on Brief Adherence Rating Scale range from 0-100, with higher scores indicating a better outcome.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Intent to Attend Measure
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Intent to Attend Measure value at intervention completion minus the value at baseline.
Scores range from 0-18.
Higher scores indicate a better outcome.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Service Engagement Scale
Time Frame: Baseline, through intervention completion (up to 3 months)
|
Change was calculated as the Service Engagement Scale value at intervention completion minus the value at baseline.
Scores on the Service Engagement Scale range from 0-42, with higher scores indicating a worst outcome.
|
Baseline, through intervention completion (up to 3 months)
|
Change in Working Alliance Inventory
Time Frame: Baseline,through intervention completion (up to 3 months)
|
Change was calculated as the Working Alliance Inventory value at intervention completion minus the value at baseline.
Scores on Working Alliance Inventory range from 36-252, with higher scores indicating a better outcome.
|
Baseline,through intervention completion (up to 3 months)
|
Satisfaction with Decision Value
Time Frame: At intervention completion (up to 3 months after baseline)
|
Scores on the Satisfaction with Decision Scale range from 6 to 30, with higher scores indicating a better outcome.
These are the values at intervention completion.
|
At intervention completion (up to 3 months after baseline)
|
Intentional Peer Support Value
Time Frame: At intervention completion (up to 3 months after baseline)
|
Scores on the Intentional Peer Support scale range from 1 to 5 with higher scores indicating a better outcome.
These are the values at intervention completion.
|
At intervention completion (up to 3 months after baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Elizabeth Thomas, Ph.D., Temple University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2020
Primary Completion (Actual)
March 31, 2023
Study Completion (Actual)
March 31, 2023
Study Registration Dates
First Submitted
July 21, 2020
First Submitted That Met QC Criteria
August 25, 2020
First Posted (Actual)
August 31, 2020
Study Record Updates
Last Update Posted (Actual)
April 17, 2024
Last Update Submitted That Met QC Criteria
March 20, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 261047
- K08MH116101 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychotic Disorders
-
Medical College of WisconsinCompletedSchizophrenia | Affective Disorders | Psychotic Disorder | Psychotic Mood Disorder
-
Søren Dinesen ØstergaardCompletedAffective Disorders, PsychoticDenmark
-
Instituto de Investigación Hospital Universitario...CompletedSchizophrenia and Disorders With Psychotic Feature | Psychotic EpisodeSpain
-
VA Office of Research and DevelopmentNot yet recruitingMI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMIHomelessness | Schizophrenia Spectrum Disorders | Psychotic Mood Disorders | Psychotic Affective Disorders | Ill-Housed PersonsUnited States
-
University of MinnesotaUniversity of California, San FranciscoCompletedPsychotic Disorders | Schizophrenia | Schizoaffective Disorder | Cognitive Impairment | Psychosis | Treatment | Psychotic Depression | Psychotic Episode | Active Control | Psychotic Mood DisordersUnited States
-
University Hospital, CaenRecruiting
-
Instituto de Investigación Hospital Universitario...Carlos III Health Institute; European Regional Development FundCompletedSchizophrenia and Disorders With Psychotic Features | Psychotic EpisodeSpain
-
Centre hospitalier de Ville-Evrard, FranceRecruiting
-
University of California, San DiegoActive, not recruitingSchizophrenia | Schizoaffective Disorder | Mood Disorder, PsychoticUnited States
-
Boston Medical CenterNational Institute of Mental Health (NIMH); Beth Israel Deaconess Medical CenterCompletedPsychotic Disorders | Psychosis | Psychotic EpisodeUnited States
Clinical Trials on Peer-Delivered Decision Support Intervention
-
Yu-Li HospitalWorkforce Development Agency of Minister of Labor, Taiwan; Tzu-Chi University... and other collaboratorsCompleted
-
UConn HealthUniversity of Texas at Austin; Oregon Social Learning CenterEnrolling by invitationSubstance Use DisordersUnited States
-
Dartmouth-Hitchcock Medical CenterHarvard University; VinfenCompletedCardiovascular Diseases | Smoking | Obesity | Diabetes | Schizophrenia | Bipolar Disorder | Blood Pressure Disorders | Cholesterol, Elevated | Major Depressive Disorder, RecurrentUnited States
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ)Completed
-
Harvard UniversityRecruitingSuicide | Distress, EmotionalUnited States
-
University of Cape TownCompleted
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedObesity | Cardiovascular Disease | Cancer | Type II Diabetes | Peer Support and Chronic DiseaseUnited States
-
University of MichiganNational Institute of Nursing Research (NINR)Completed
-
Universiti Putra MalaysiaNot yet recruitingTreatment Adherence and CompliancePakistan
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)CompletedPersonality Disorders | Depression | Schizophrenia | Anxiety Disorders | Bipolar Disorder | Cognitive DisordersUnited States